Research News

Research News Image

Initial Study Shows Promise for Biomarker-Based PTSD Screening

Sep 25 2019
An accurate diagnosis is the first step to care and recovery. Diagnosing mental illness can be difficult, however, because symptoms are primarily self-reported. To provide clinicians with an objective screening tool for Posttraumatic Stress Disorder (PTSD), researchers from NYU, Harvard University and the US Army created a biomarker panel that was approximately 80% accurate in identifying PTSD in an initial study. Although the panel requires further testing in a larger population, it is a significant step forward for objective, reliable screening tools for mental health conditions. To learn more, please see the study in JAMA